Novartis hands investors Alcon spin-off and $5bn share buyback
Eyecare business had been problematic since Novartis bought it for $52 billion in 2011
Novartis plans to buy back $5bn in stock over next two years
Pharma firm will expand in faster-growing areas of healthcare
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices